Effects of dietary protease and protease-probiotic combination on growth performance, nutrient digestibility, and intestinal immune response in broiler chickens Authors: Deependra Paneru, Venkata Sesha Reddy Choppa, Jihwan Lee, Hanseo Ko, Milan Kumar Sharma, Woo Kyun Kim Published: 2026 ABSTRACT AbstractA study was conducted to evaluate the effects of dietary supplementation with a microbial protease alone or in combination with probiotic components on growth performance, nutrient utilization, amino acid digestibility, and intestinal immune response in broiler chickens. A total of 240 one-day-old male Cobb 500 broilers were randomly assigned to 3 dietary treatments with 8 replicate pens of 10 birds each: a control diet, control supplemented with 0.1% Pearlzyme 1 (microbial protease), and control supplemented with 0.1% Pearlzyme 2 (microbial protease combined with probiotic components). Birds were reared for 21 d and fed a starter diet from d 0 to 12 and a grower diet from d 13 to 21. Growth performance was measured throughout the experiment, and energy utilization, nitrogen utilization, and apparent ileal digestibility of amino acids were determined during the grower phase. To evaluate intestinal immune response, 1 bird per pen was challenged with lipopolysaccharide on d 19, and intestinal morphology and ileal gene expression were assessed 4 h later. Both supplements increased apparent metabolizable energy (P = 0.003), nitrogen-corrected apparent metabolizable energy (P = 0.003), gross energy digestibility (P = 0.014), and dry matter digestibility (P = 0.002) compared with the control diet. Pearlzyme 2 increased feed intake (P = 0.018), body weight gain (P = 0.028), and nitrogen retention (P = 0.030) during the grower phase. Pearlzyme 1 improved apparent ileal digestibility of several amino acids, including threonine (P = 0.047), phenylalanine (P = 0.035), tyrosine (P = 0.034), and cysteine (P = 0.018). Intestinal morphology and tight junction gene expression were not affected by dietary treatment (P > 0.05). However, Pearlzyme 2 reduced ileal expression of interleukin-1 beta (P < 0.001) and interleukin-10 (P = 0.005) following lipopolysaccharide challenge. These findings suggest that microbial protease supplementation can improve nutrient utilization in broiler diets, and combining protease with probiotic components may provide additional benefits for growth and intestinal immune balance in antibiotic-reduced poultry production systems.Keywords: Broiler chickens, Protease, Probiotics, Nutrient digestibility, Intestinal immunity Introduction Feed represents the largest variable cost in broiler production, often accounting for approximately 60-70% of overall production expenses (Jie et al., 2024; Sugiharto and Ranjitkar, 2019). Simultaneously, the poultry industry has faced increasing pressure to reduce routine use of in-feed antibiotic growth promoters (AGPs) due to antimicrobial resistance concerns and regulatory restrictions in many regions; for example, approvals for AGPs were withdrawn in the European Union beginning in 2006, and international public health agencies have recommended limiting antibiotic use for growth promotion and prophylaxis in healthy animals (Castanon, 2007). These challenges have accelerated development and adoption of nutritional interventions that improve nutrient utilization while supporting gastrointestinal function and immune resilience. Exogenous feed enzymes are widely used in poultry diets to mitigate anti-nutritional constraints and improve digestion, although their efficacy can vary with diet composition, ingredient quality, and physiological conditions (Ravindran, 2013). Proteases are used to improve protein hydrolysis and increase the availability of amino acids and energy, potentially enabling more precise diet formulation with reduced safety margins (Rodríguez-Soriano et al., 2025). Protease efficacy may be especially relevant in young broilers because the gastrointestinal tract is immature immediately after hatch, with limited digestive capacity that develops rapidly as digestive enzyme secretion and absorptive surface area increase (Ravindran and Abdollahi, 2021). Across studies, mono-component protease supplementation has been reported to improve apparent ileal amino acid digestibility, with larger responses when baseline digestibility is low and for certain economically important amino acids (Cowieson and Roos, 2013). In addition to ileal digestibility effects, protease supplementation has been associated with improvements in energy and nitrogen utilization and changes in energy partitioning efficiency in broilers under different feeding conditions (McCafferty et al., 2022). Improving protein utilization may also have implications for gut health beyond nutrient availability. Protein that escapes digestion in the small intestine can be fermented by distal gut microbiota, yielding metabolites such as ammonia, biogenic amines, and phenolic/indolic compounds that are associated with impaired gut function and reduced growth (Elling-Staats et al., 2022). As poultry production increasingly incorporates variable or less digestible ingredients, strategies that reduce indigestible protein flow to the hindgut may help stabilize the intestinal environment and reduce nutrition-immunity tradeoffs (Elling-Staats et al., 2022). Probiotics, commonly defined as live microorganisms that confer health benefits to the host when administered in adequate amounts, are widely investigated as alternatives to AGPs in poultry production (Jha et al., 2020; Kulkarni et al., 2022). Several mechanisms have been proposed to explain their beneficial effects, including improvement of growth performance, regulation of nutrient transporters, competitive exclusion of pathogenic microorganisms, production of antimicrobial metabolites, stimulation of intestinal fermentation, modulation of mucosal immune responses, enhancement of antioxidant defense system, suppression of inflammation, and improvement of intestinal epithelial barrier integrity (Latif et al., 2023; Li et al., 2026; Ren et al., 2026; Yu et al., 2026). A meta-analysis focusing on gene expression and intestinal barrier outcomes reported that probiotic supplementation can increase the expression of tight junction and mucin-related genes and may reduce intestinal inflammatory signaling in challenged birds, although these responses vary depending on factors such as bird age, probiotic strain, dosage, and health status (Yosi and Metzler-Zebeli, 2023). Among probiotic genera, spore-forming Bacillus strains are of particular interest for feed applications because they survive feed processing and gastric transit and can secrete exogenous digestive enzymes such as proteases, amylases, and lipases that complement endogenous digestion (Bromfield et al., 2024). When used mono-strain or alone, Bacillus-based probiotics improve growth performance, intestinal histomorphology, and both immune and antioxidant status in broilers, with these performance benefits being most pronounced under inflammatory or pathogen challenge (Cai et al., 2024; Paneru et al., 2023; Wang et al., 2020). Furthermore, Bacillus-based probiotics have also been associated with reduced expression of pro-inflammatory cytokines during immune challenges, supporting their potential role in maintaining immune homeostasis during inflammatory stress (Rodríguez et al., 2023). When combined with an exogenous protease, probiotics may provide complementary benefits by suppressing pathogenic bacteria and favoring saccharolytic taxa whose metabolites support the mucosal barrier and moderate inflammation (Cai et al., 2024; Yang et al., 2025). Most existing studies have evaluated proteases and probiotics independently or have combined probiotics with carbohydrases such as xylanase (Luo et al., 2023; Nusairat et al., 2022), and the few studies pairing a protease with a probiotic have supplemented all groups with the enzyme, precluding isolation of the probiotic's incremental effect (Mushtaq et al., 2024). The present study is novel in two respects. First, it assesses both nutrient digestibility/growth performance and the intestinal immune response to an acute lipopolysaccharide (LPS) challenge within the same experiment, whereas these outcomes are typically examined separately. Second, because Pearlzyme 1 and Pearlzyme 2 share the same Bacillus clausii-derived protease and differ only in the inclusion of viable B. clausii, the current study estimates the incremental contribution of the probiotic on top of a constant protease background. The objective of the present study was to determine whether adding a viable probiotic to a protease-supplemented diet provides benefit beyond the protease alone. Two products sharing the same Bacillus clausii-derived protease and differing only in the inclusion of viable B. clausii (Pearlzyme 1 and Pearlzyme 2) were fed in a diet formulated with a diverse combination of ingredients. Growth performance, energy utilization, nitrogen utilization, and apparent ileal digestibility of amino acids were determined, and intestinal morphology and ileal expression of genes related to inflammatory response and barrier function were evaluated following an acute lipopolysaccharide challenge (Shang et al., 2015). It was hypothesized that dietary protease supplementation would improve nutrient digestibility and energy utilization, and that the addition of probiotic components would further support intestinal health by moderating inflammatory signaling and maintaining intestinal barrier responses following LPS challenge. Materials & methods Ethics statement All animal procedures were reviewed and approved by the Institutional Animal Care and Use Committee at the University of Georgia (A2022 04-029) and complied with the Guide for the Care and Use of Agricultural Animals in Research and Teaching (FASS, 2020). Experimental design and diets A total of 240 one-day-old male Cobb 500 broiler chicks were obtained from a Cobb-Vantress hatchery (Cleveland, GA) and individually weighed upon arrival. Birds were randomly assigned to 3 dietary treatments with 8 replicate pens per treatment and 10 birds per pen. The pen served as the experimental unit for all growth performance and digestibility measurements. The dietary treatments consisted of: (1) a corn-soybean meal-based control diet (CON), (2) CON supplemented with 0.1% Pearlzyme 1 (PAR1), and (3) CON supplemented with 0.1% Pearlzyme 2 (PAR2). The Pearlzyme products were provided by Pearlzyme Inc. (Incheon, Korea) and SoltonBiochem Inc (Seoul, Korea). Pearlzyme 1 is a microbial protease preparation produced from Bacillus clausii that contains a haloalkalophilic serine protease with a declared activity of 10,000 U/g. Pearlzyme 2 contains the same protease preparation combined with Bacillus clausii at 1 × 106/g according to the manufacturer’s specifications. Birds were fed a two-phase feeding program consisting of a starter diet from d 0 to 12 and a grower diet from d 13 to 21. Experimental diets were formulated to meet or exceed the nutrient requirements for Cobb 500 broilers during the respective growth phases (Cobb-vantress, 2022). To better represent practical commercial feeding conditions, the diets were formulated using a diverse combination of commonly used feed ingredients, including corn, soybean meal, corn distillers dried grains with solubles (DDGS), wheat, meat and bone meal, and cottonseed meal. The ingredient composition of the starter and grower diets is presented in Table 1. Pearlzyme products were included in the experimental diets at 0.1% by replacing an equivalent amount of an inert filler to maintain similar nutrient composition across the treatments. Prior to mixing the feed, the required amount of Pearlzyme product was weighed and premixed with a small portion of the basal diet to ensure uniform distribution. The premix was then incorporated into the complete diet and mixed in a horizontal mixer to achieve homogeneous distribution of ingredients and additives. All diets were prepared in mash form. In the grower diet, chromic oxide (0.30%) was included as an indigestible marker for determination of nutrient digestibility. Table 1Ingredient composition of the experimental starter (d 0-12) and grower (d 13-21) diets (%, as-fed basis).Ingredient, %Starter dietGrower dietCorn58.2457.71Soybean meal23.0022.30Corn DDGS13.003.00Wheat3.003.00Meat and bone meal3.003.00Cottonseed meal3.003.00Dicalcium phosphate1.000.79Limestone1.001.00DL-Methionine0.300.40L-Lysine HCl0.500.46L-Threonine0.500.20L-Tryptophan0.30–L-Valine0.400.09L-Arginine–0.01L-Isoleucine–0.09Sodium chloride0.290.40Vitamin premix20.100.10Mineral premix30.080.08Soybean oil2.002.00Chromic oxide (Cr2O3)–0.30Inert filler40.302.08Total100.00100.001Corn distillers dried grains with solubles.2Vitamin premix supplied per kg of diet: vitamin A, 3,527 IU; vitamin D₃, 1,400 ICU; vitamin E, 19.4 IU; vitamin B₁₂, 0.008 mg; menadione, 1.1 mg; riboflavin, 3.53 mg; D-pantothenic acid, 5.47 mg; thiamine, 0.97 mg; niacin, 20.28 mg; vitamin B₆, 1.45 mg; folic acid, 0.57 mg; biotin, 0.08 mg.3Mineral premix supplied per kg of diet: Ca, 25.6 mg; Mn, 107.2 mg; Zn, 85.6 mg; Mg, 21.44 mg; Fe, 21.04 mg; Cu, 3.2 mg; I, 0.8 mg; Se, 0.32 mg.4In both starter and grower diets: Pearlzyme enzymes (0.1%) replaced an equivalent amount of inert filler in supplemented diets. Ingredient composition of the experimental starter (d 0-12) and grower (d 13-21) diets (%, as-fed basis). Corn distillers dried grains with solubles. Vitamin premix supplied per kg of diet: vitamin A, 3,527 IU; vitamin D₃, 1,400 ICU; vitamin E, 19.4 IU; vitamin B₁₂, 0.008 mg; menadione, 1.1 mg; riboflavin, 3.53 mg; D-pantothenic acid, 5.47 mg; thiamine, 0.97 mg; niacin, 20.28 mg; vitamin B₆, 1.45 mg; folic acid, 0.57 mg; biotin, 0.08 mg. Mineral premix supplied per kg of diet: Ca, 25.6 mg; Mn, 107.2 mg; Zn, 85.6 mg; Mg, 21.44 mg; Fe, 21.04 mg; Cu, 3.2 mg; I, 0.8 mg; Se, 0.32 mg. In both starter and grower diets: Pearlzyme enzymes (0.1%) replaced an equivalent amount of inert filler in supplemented diets. Birds were housed in battery cages in an environmentally controlled room. Each replicate cage was equipped with a feeder and nipple drinker system, and birds had ad libitum access to feed and water throughout the 21-d experimental period. Environmental conditions were maintained according to Cobb broiler management guidelines (Cobb-Vantress, 2021). Room temperature was maintained at approximately 33°C at placement and gradually reduced to 24°C by d 21 to meet the thermal requirements of growing broilers. A lighting program was implemented following standard broiler management recommendations, with 24 h of light on d 1, 22 h of light on d 2, and 18 h of light from d 3 to 21. Birds were monitored at least twice daily for health status and general welfare. Mortality was recorded as it occurred, and feed intake (FI) and performance calculations were adjusted accordingly. Growth performance measurements Growth performance parameters were measured throughout the 21-d experimental period. Birds and feed were weighed at placement (d 0) and subsequently at weekly intervals (d 7, 14, and 21). Body weight gain (BWG), FI, and feed conversion ratio (FCR) were calculated for each period (d 0-7, 8-14, and 15-21) as well as for the overall experimental period (d 0-21). Feed intake was determined by subtracting the amount of feed remaining in each feeder from the amount of feed provided during each measurement period. Body weight gain was calculated as the difference between the average body weight (BW) at the beginning and end of each interval. The FCR was calculated as the ratio of FI to BWG. Mortality was recorded daily, and FI and FCR were adjusted to account for mortalities when applicable. All performance data were expressed on a per-bird basis, and the pen served as the experimental unit for statistical analysis. Energy and nitrogen utilization Energy and nitrogen utilization was determined during the grower phase using fecal samples collected from birds fed diets containing chromic oxide as an indigestible marker. From d 18 to 21, fresh fecal samples were collected twice daily from trays placed beneath each cage to avoid contamination with feathers and feed. Collected samples were pooled within pen, immediately frozen (−20°C), and subsequently freeze-dried and ground through a 1-mm screen prior to chemical analyses. Feed and fecal samples were analyzed for dry matter, gross energy, and nitrogen. Gross energy was determined using a bomb calorimeter (IKA Calorimeter C1; IKA Works Inc., Wilmington, NC) (Wang et al., 2021). Nitrogen content in feed and digesta was determined using the LECO system as indicated by AOAC International (AOAC, 2000). Chromic oxide concentrations in feed and feces were measured spectrophotometrically after acid digestion (Teng et al., 2020). Energy utilization parameters were calculated using the index method based on chromium marker concentrations in feed and feces. Apparent metabolizable energy (AME) and nitrogen-corrected apparent metabolizable energy (AMEn) were calculated as where GEdiet is the gross energy concentration of the diet (kcal/kg), GEfeces is the gross energy concentration of feces (kcal/kg), Crdiet is the chromium concentration in the diet (%), and Crfeces is the chromium concentration in feces (%). Nitrogen-corrected apparent metabolizable energy was calculated as where 8.22 represents the energetic equivalent (kcal/g) of uric acid nitrogen in poultry and Nretained represents nitrogen retained. Nitrogen (N) retained was calculated as Gross energy digestibility and dry matter digestibility were calculated using the marker ratio method: where DMdiet and DMfeces represent dry matter concentrations of the diet and feces, respectively. Nitrogen intake was calculated from FI and dietary nitrogen concentration as where FI is feed intake (g/bird) and Ndiet is nitrogen concentration of the diet. Nitrogen retention efficiency was calculated as All calculations were performed using values determined from feed and fecal samples collected during the grower phase. Apparent ileal digestibility of amino acids Apparent ileal digestibility (AID) of amino acids was determined at the end of the experiment (d 21). On d 21, two birds per pen with BW close to the pen average were selected and euthanized by cervical dislocation. The ileum was defined as the portion of the small intestine extending from Meckel’s diverticulum to approximately 2 cm anterior to the ileocecal junction. Ileal digesta were gently flushed with distilled water into collection containers, pooled within pen, and immediately frozen at −20°C. Digesta samples were subsequently freeze-dried and ground for analysis. Feed and ileal digesta samples were analyzed for amino acid concentrations using high-performance liquid chromatography (HPLC) after acid hydrolysis. Methionine and cysteine were determined following performic acid oxidation prior to hydrolysis, whereas tryptophan was determined after alkaline hydrolysis. Chromic oxide concentration in ileal digesta was analyzed using the same procedure described for fecal samples. Apparent ileal digestibility coefficients for individual amino acids were calculated using the marker ratio method based on the concentrations of amino acids and chromic oxide in diet and ileal digesta. Apparent ileal digestibility of amino acids was calculated as where Crdiet and Crdigesta represent chromium concentrations in the diet and ileal digesta, respectively, and AAdiet and AAdigesta represent the concentrations of a given amino acid in the diet and ileal digesta. Lipopolysaccharide challenge and intestinal response measurements To evaluate the ability of dietary protease and protease plus probiotic supplementation to modulate intestinal responses during an acute inflammatory challenge, one bird per pen (n = 8 birds per treatment) with BW close to the pen average was selected at 19 d of age for an LPS challenge. Birds were intraperitoneally injected with 2 mg/kg BW of Salmonella enterica serovar Enteritidis LPS (ATCC 13076; L4774, Sigma-Aldrich, St. Louis, MO) dissolved in sterile PBS to induce an acute inflammatory response. This LPS dose and challenge model have been previously validated (Shang et al., 2015), to induce acute intestinal inflammatory response in broilers. Therefore, all birds received the same LPS challenge, and the dietary treatments were compared under identical inflammatory conditions rather than against a non-challenged control. Four hours after LPS administration, birds were euthanized by cervical dislocation, and intestinal tissues were immediately collected for morphological and molecular analyses. Intestinal Morphology. Approximately 2-cm segments of the duodenum, jejunum, and ileum were collected and gently flushed with phosphate-buffered saline (PBS) to remove intestinal contents. Tissue samples were fixed in 10% phosphate-buffered formalin, dehydrated, embedded in paraffin, and sectioned at 4 μm thickness. Sections were stained with hematoxylin and eosin (H&E) using standard histological procedures. Morphological measurements were performed using a light microscope equipped with an image analysis system. Villus height (VH) was measured as the distance from the tip of the villus to the villus-crypt junction, whereas crypt depth (CD) was measured from the base of the crypt to the villus-crypt junction. The villus height to crypt depth ratio (VH:CD) was subsequently calculated. Multiple well-oriented villi and associated crypts were measured for each sample, and the average values were used for statistical analysis Immune and Tight Junction Gene Expression. Ileal mucosal samples were collected to evaluate the expression of immune-related cytokines and tight junction proteins. The expression of pro- and anti-inflammatory cytokines, including interleukin-1 beta (IL-1β), interleukin-10 (IL-10), inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and interferon-gamma (IFN-γ), was measured to assess intestinal immune responses following LPS challenge. In addition, the expression of tight junction proteins claudin-1 (CLDN1) and occludin (OCLN) was quantified to evaluate intestinal barrier integrity. RNA Isolation, cDNA Synthesis, and Quantitative Real-Time PCR. Total RNA was extracted from ileal samples using QIAzol Lysis Reagent (Qiagen, Germantown, MD) according to the manufacturer’s instructions. The purity and concentration of RNA were assessed by NanoDrop (Thermo Fisher Scientific, Waltham, MA) prior to downstream analysis. Complementary DNA (cDNA) was synthesized from total RNA using a High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific, Waltham, MA) following the manufacturer’s protocol. Gene-specific primers for each target gene were designed and verified for sequence specificity using the National Center for Biotechnology Information (NCBI) database, and the primer sequences are provided in Table 2. Quantitative real-time PCR (qRT-PCR) was performed in duplicate reactions containing nuclease-free water, forward and reverse primers, cDNA template, and Taq Universal SYBR Green Supermix (Bio-Rad, Hercules, CA) as the fluorescent detection reagent. Amplification was conducted using a QuantStudio 3 system (Applied Biosystems, Foster City, CA). Relative gene expression levels were calculated using the 2⁻ΔΔCt method and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the housekeeping gene for normalization. Gene expression values were expressed as fold changes relative to the control group. Table 2Primer sequences used for quantitative real-time PCR analysis of immune and tight junction genes in broiler ileum.Gene1Forward Primer (5′–3′)Reverse Primer (5′–3′)GenBank Accession No.IL-1βCGACATCTTCGACATCAACCTGTTGAGCCTCACTTTCTGGNM_204524.2IL-10GCTGCGCTTCTACACAGATGCTCCTCTTCTCGCAGGTGAANM_001004414.4iNOSACTCCTTGCTCACCCTGAAACACTGGAGTGAGCTGCAAAGNM_204961.2COX-2TGCAAGTGGAACTCGTTCTGCCGATCAAATCCTGTTGTCANM_001167718.2IFN-γAGCCGCACATCAAACACATACGCTGGATTCTCAAGTCGTTNM_205149.2CLDN1GGAGGATGACCAGGTGAAGAAGCCACTCTGTTGCCATACCNM_001013611.2OCLNTACTACCCCTCGGGCACCTACTGATCCTTCCCCTTCTCCTNM_205128.1GAPDHGCTAAGGCTGTGGGGAAAGTTCAGCAGCAGCCTTCACTACNM_204305.21Abbreviations: IL-1β, interleukin-1 beta; IL-10, interleukin-10; iNOS, inducible nitric oxide synthase; COX-2, cyclooxygenase-2, IFN-γ, interferon-gamma; CLDN1, claudin-1; OCLN, occludin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase. Primer sequences used for quantitative real-time PCR analysis of immune and tight junction genes in broiler ileum. Abbreviations: IL-1β, interleukin-1 beta; IL-10, interleukin-10; iNOS, inducible nitric oxide synthase; COX-2, cyclooxygenase-2, IFN-γ, interferon-gamma; CLDN1, claudin-1; OCLN, occludin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase. Statistical analysis All data were analyzed using one-way ANOVA with dietary treatment as the main effect. The experimental design consisted of three dietary treatments: control (CON), CON supplemented with 0.1% Pearlzyme 1 (PAR1), and CON supplemented with 0.1% Pearlzyme 2 (PAR2). For growth performance, energy and nitrogen utilization, apparent ileal digestibility of amino acids, and intestinal morphology, the pen served as the experimental unit. For LPS challenge measurements, the individual bird was considered the experimental unit. Data were analyzed using SAS software (SAS Institute Inc., Cary, NC). When a significant treatment effect was observed, means were separated using Tukey’s multiple comparison test. Differences among treatments were considered statistically significant at P ≤ 0.05, whereas 0.05 < P ≤ 0.10 was considered a statistical tendency (Choi et al., 2021). All results are presented as means with pooled standard error of the mean (SEM). Prior to analysis, data were checked for normality and homogeneity of variance to ensure that assumptions of ANOVA were satisfied. Results Growth performance Growth performance of broiler chickens fed the control diet (CON) or diets supplemented with Pearlzyme 1 (PAR1) or Pearlzyme 2 (PAR2) from 0 to 21 d of age is presented in Table 3. Body weight at d 7 and d 14 was not affected by dietary treatments (P > 0.05). At d 21, birds fed PAR2 tended to have a higher BW compared with those fed CON and PAR1 (P = 0.090). Similarly, BWG during d 0-7 and d 8-14 was not affected by dietary treatment (P > 0.05). However, during d 15-21, birds fed PAR2 showed significantly higher BWG compared with those fed PAR1, whereas CON birds showed intermediate values (P = 0.028). Overall BWG from d 0-14 and d 0-21 was not significantly affected by treatment, although birds fed PAR2 tended to show the highest BWG over the entire experimental period (P = 0.090). Table 3Growth performance of broiler chickens fed a control diet (CON) or diets supplemented with Pearlzyme 1 (PAR1) or Pearlzyme 2 (PAR2) from 0 to 21 d of age.Item1CONPAR1PAR2SEMP-valueBody weight (g)d 0 (Initial)4242420.020.759d 71281321312.30.423d 144064084065.70.946d 2179979784315.90.090Body weight gain (g)d 0-78690892.30.420d 8-142782762754.10.865d 15-21393ab389b438a13.10.028d 0-143643673645.70.946d 0-2175775580215.90.090Feed intake (g)d 0-71061091082.90.774d 8-143653623715.60.520d 15-21635b636b672a9.40.018d 0-144714714797.240.671d 0-2111071106115015.30.086Feed conversion ratiod 0-71.231.211.220.0270.765d 8-141.311.311.350.0190.238d 15-211.631.641.540.0430.186d 0-141.291.281.320.0180.397d 0-211.471.471.440.0230.614a-bMeans within a row with different superscripts differ significantly (P < 0.05).1Values are presented as least squares means (n = 8 pens/treatment). CON = control diet; PAR1 = CON + 0.1% Pearlzyme 1; PAR2 = CON + 0.1% Pearlzyme 2; SEM = pooled standard error of the mean. Growth performance of broiler chickens fed a control diet (CON) or diets supplemented with Pearlzyme 1 (PAR1) or Pearlzyme 2 (PAR2) from 0 to 21 d of age. Means within a row with different superscripts differ significantly (P < 0.05). Values are presented as least squares means (n = 8 pens/treatment). CON = control diet; PAR1 = CON + 0.1% Pearlzyme 1; PAR2 = CON + 0.1% Pearlzyme 2; SEM = pooled standard error of the mean. Feed intake during d 0-7 and d 8-14 did not differ among the treatments (P > 0.05). However, during d 15-21, birds fed PAR2 consumed more feed than birds fed CON or PAR1 (P = 0.018). Cumulative FI from d 0-14 and d 0-21 was not significantly affected by treatment, although birds fed PAR2 tended to have higher overall FI compared to the other treatments (P = 0.086). However, FCR was not affected by dietary treatment during any of the measured periods (P > 0.05). Overall FCR from d 0-21 was also similar among the treatments (P = 0.614). Energy utilization Energy utilization during the grower phase is presented in Table 4. Dietary supplementation significantly affected apparent metabolizable energy (AME) and nitrogen-corrected apparent metabolizable energy (AMEn). Birds fed diets supplemented with PAR1 and PAR2 had higher AME compared with birds fed the control diet (P = 0.003). Similarly, AMEn was significantly higher in PAR1 and PAR2 fed birds than that in CON-fed birds (P = 0.003). Table 4Energy utilization of broiler chickens fed a control diet (CON) or diets supplemented with Pearlzyme 1 (PAR1) or Pearlzyme 2 (PAR2) during d 14-21.Item1CONPAR1PAR2SEMP-valueAME (kcal/kg)2863b2962a2937a18.40.003AMEn (kcal/kg)2727b2824a2792a17.80.003GE digestibility (%)72.7b74.6a74.3a0.470.014DM digestibility (%)71.7b73.5a73.7a0.390.002a-bMeans within a row with different superscripts differ significantly (P < 0.05).1Values are least squares means (n = 8 pens/treatment). SEM = pooled standard error of the mean.CON = control diet; PAR1 = CON + 0.1% Pearlzyme 1; PAR2 = CON + 0.1% Pearlzyme 2. AME = apparent metabolizable energy; AMEn = nitrogen-corrected apparent metabolizable energy; GE = gross energy; DM = dry matter. Energy utilization of broiler chickens fed a control diet (CON) or diets supplemented with Pearlzyme 1 (PAR1) or Pearlzyme 2 (PAR2) during d 14-21. Means within a row with different superscripts differ significantly (P < 0.05). Values are least squares means (n = 8 pens/treatment). SEM = pooled standard error of the mean.CON = control diet; PAR1 = CON + 0.1% Pearlzyme 1; PAR2 = CON + 0.1% Pearlzyme 2. AME = apparent metabolizable energy; AMEn = nitrogen-corrected apparent metabolizable energy; GE = gross energy; DM = dry matter. Gross energy digestibility was also influenced by dietary treatment. Birds fed PAR1 and PAR2 had significantly higher gross energy digestibility than those fed the control diet (P = 0.014). Similarly, dry matter digestibility was significantly higher in birds fed PAR1 and PAR2 compared with CON-fed birds (P = 0.002). No significant differences were observed between the two enzyme-supplemented treatments (PAR1 and PAR2) for AME, AMEn, gross energy digestibility, or dry matter digestibility (P > 0.05). Nitrogen utilization Nitrogen utilization during the grower phase is presented in Table 5. Nitrogen intake was significantly affected by dietary treatment (P = 0.018). Birds fed PAR2 consumed more nitrogen than those fed CON or PAR1, whereas no difference was observed between CON and PAR1. Nitrogen retention also differed among the treatments (P = 0.030). Birds receiving PAR2 showed significantly higher nitrogen retention compared with CON-fed birds, while PAR1-fed birds exhibited intermediate values and did not differ from either CON or PAR2. However, nitrogen retention efficiency was not affected by dietary treatment (P = 0.110). Table 5Nitrogen utilization of broiler chickens fed a control diet (CON) or diets supplemented with Pearlzyme 1 (PAR1) or Pearlzyme 2 (PAR2) during d 14-21.Item1CONPAR1PAR2SEMP-valueN intake (g/bird)20.9b20.9b22.1a0.310.018N retention (g/bird)16.5b16.8ab17.6a0.270.030N retention efficiency (%)78.980.479.60.480.110a-bMeans within a row with different superscripts differ significantly (P < 0.05).1Values are least squares means (n = 8 pens/treatment). SEM = pooled standard error of the mean. CON = control diet; PAR1 = CON + 0.1% Pearlzyme 1; PAR2 = CON + 0.1% Pearlzyme 2. Nitrogen utilization of broiler chickens fed a control diet (CON) or diets supplemented with Pearlzyme 1 (PAR1) or Pearlzyme 2 (PAR2) during d 14-21. Means within a row with different superscripts differ significantly (P < 0.05). Values are least squares means (n = 8 pens/treatment). SEM = pooled standard error of the mean. CON = control diet; PAR1 = CON + 0.1% Pearlzyme 1; PAR2 = CON + 0.1% Pearlzyme 2. Apparent ileal digestibility of amino acids Apparent ileal digestibility (AID) of amino acids is presented in Table 6. Dietary supplementation had limited effects on most amino acids; however, the digestibility values of several key individual amino acids were significantly affected by treatment. Digestibility of threonine (Thr) was greater in birds fed PAR1 compared with CON, whereas PAR2 showed intermediate values (P = 0.047). Similarly, phenylalanine (Phe) digestibility was significantly higher in PAR1-fed birds than that in CON-fed birds, with PAR2 again showing intermediate values (P = 0.035). Digestibility of tyrosine (Tyr) followed a similar pattern, with PAR1 showing greater Tyr digestibility than CON and PAR2 (P = 0.034). In addition, cysteine (Cys) digestibility was significantly improved in birds fed PAR1 compared with CON, whereas PAR2 was intermediate (P = 0.018). Table 6Apparent ileal digestibility (%) of amino acids in broiler chickens fed a control diet (CON) or diets supplemented with Pearlzyme 1 (PAR1) or Pearlzyme 2 (PAR2) at 21 d of age.Amino acid1CONPAR1PAR2SEMP-valueLysine84.986.485.60.4160.067Methionine91.792.692.00.3000.150Threonine75.7b77.9a76.9ab0.5860.047Tryptophan82.083.382.70.4920.188Arginine85.987.186.00.3820.076Isoleucine80.081.880.70.6730.206Leucine80.782.481.50.5380.095Valine78.680.579.50.7100.188Histidine79.481.280.40.5140.069Phenylalanine80.7b82.5a82.0ab0.4790.035Alanine79.181.080.10.5550.084Aspartic acid76.377.976.90.5820.197Glutamic acid84.185.384.60.4250.146Glycine73.775.374.70.4890.094Proline79.881.180.20.4700.148Serine76.878.476.90.5980.117Tyrosine81.5b82.8a82.6ab0.3700.034Cysteine66.4b70.1a69.4ab0.8670.018a-bMeans within a row with different superscripts differ significantly (P < 0.05).1Values are presented as least squares means (n = 8 pens/treatment). CON = control diet; PAR1 = diet with additive 1; PAR2 = diet with additive 2; SEM = pooled standard error of the mean. Apparent ileal digestibility (%) of amino acids in broiler chickens fed a control diet (CON) or diets supplemented with Pearlzyme 1 (PAR1) or Pearlzyme 2 (PAR2) at 21 d of age. Means within a row with different superscripts differ significantly (P < 0.05). Values are presented as least squares means (n = 8 pens/treatment). CON = control diet; PAR1 = diet with additive 1; PAR2 = diet with additive 2; SEM = pooled standard error of the mean. For the remaining amino acids, including lysine, methionine, tryptophan, arginine, isoleucine, leucine, valine, histidine, alanine, aspartic acid, glutamic acid, glycine, proline, and serine, dietary treatments did not significantly affect AID (P > 0.05). However, lysine, arginine, leucine, histidine, alanine, and glycine tended to show improved digestibility in birds fed PAR1 compared with CON (P < 0.10). Intestinal morphology in LPS-challenged birds Intestinal morphology of LPS-challenged broiler chickens fed the control diet (CON) or diets supplemented with Pearlzyme 1 (PAR1) or Pearlzyme 2 (PAR2) is presented in Fig. 1. Dietary treatments did not significantly affect VH in the duodenum, jejunum, and ileum of LPS-challenged birds (P > 0.05). Similarly, CD was not influenced by dietary treatment in any intestinal segment (P > 0.05). Consequently, VH:CD was not significantly affected by dietary treatments in the duodenum, jejunum, or ileum of LPS-challenged birds (P > 0.05). Intestinal morphology of LPS-challenged broiler chickens fed a control diet (CON) or diets supplemented with Pearlzyme 1 (PAR1) or Pearlzyme 2 (PAR2). (A) Villus height (VH), (B) crypt depth (CD), and (C) villus height to crypt depth ratio (VH:CD) measured in the duodenum, jejunum, and ileum. Values are presented as least squares means ± SEM (n = 8 birds/treatment). VH = villus height; CD = crypt depth; VH:CD = villus height to crypt depth ratio; CON = control diet; PAR1 = CON + 0.1% Pearlzyme 1; PAR2 = CON + 0.1% Pearlzyme 2. Tight junction gene expression in LPS-challenged birds The relative mRNA expression of tight junction proteins in the ileum of LPS-challenged broiler chickens is presented in Fig. 2. Dietary treatments tended to affect the expression of claudin-1 (CLDN1; P = 0.095). Birds fed PAR1 and PAR2 showed numerically lower CLDN1 expression compared with CON-fed birds, with the lowest expression observed in the PAR2 group. However, occludin (OCLN) expression was not significantly affected by dietary treatment (P = 0.194). Expression of tight junction genes in the ileum of LPS-challenged broiler chickens fed a control diet (CON) or diets supplemented with Pearlzyme 1 (PAR1) or Pearlzyme 2 (PAR2). Rel-ative mRNA expression of claudin-1 (CLDN1) and occludin (OCLN) was determined by quantita-tive real-time PCR and normalized to GAPDH. Gene expression levels were calculated using the 2⁻ΔΔCt method and expressed as fold change relative to the control group. Values are presented as least squares means ± SEM (n = 8 birds/treatment). CON = control diet; PAR1 = CON + 0.1% Pearlzyme 1; PAR2 = CON + 0.1% Pearlzyme 2. Cytokine gene expression in LPS-challenged birds The relative mRNA expression of cytokine genes in the ileum of LPS-challenged broiler chickens is presented in Fig. 3. Dietary treatments significantly affected the expression of interleukin-1β (IL-1β; P < 0.001). Birds fed PAR2 had significantly lower IL-1β expression compared with those fed CON and PAR1, whereas no difference was observed between CON and PAR1. Similarly, the expression of interleukin-10 (IL-10) differed among the treatments (P = 0.005). Birds receiving PAR2 showed lower IL-10 expression compared with CON and PAR1, whereas CON and PAR1 did not differ. In contrast, inducible nitric oxide synthase (iNOS) expression was not significantly affected by dietary treatment (P = 0.105). Similarly, the expression of cyclooxygenase-2 (COX-2) and interferon-γ (IFN- γ) was not significantly influenced by dietary treatments (P > 0.05). Expression of cytokine and inflammatory mediator genes in the ileum of LPS-challenged broiler chickens fed a control diet (CON) or diets supplemented with Pearlzyme 1 (PAR1) or Pearlzyme 2 (PAR2). Relative mRNA expression of interferon-γ (IFN-γ), interleukin-1β (IL-1β), interleukin-10 (IL-10), inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) was determined by quantitative real-time PCR and normalized to GAPDH. Gene expression levels were calculated using the 2⁻ΔΔCt method and expressed as fold change relative to the control group. Values are presented as least squares means ± SEM (n = 8 birds/treatment). CON = control diet; PAR1 = CON + 0.1% Pearlzyme 1; PAR2 = CON + 0.1% Pearlzyme 2. a-b Different superscripts indicate significant differences among treatments (P < 0.05). Discussion The present study aimed to evaluate the effects of dietary supplementation with two Pearlzyme products, a haloalkalophilic serine protease derived from Bacillus clausii. (PAR1) and the same protease combined with Bacillus clausii. (PAR2), on growth performance, nutrient utilization, amino acid digestibility, and intestinal responses in broiler chickens, including under LPS challenge to simulate immune stress. Overall, both supplements improved energy utilization, but the two Pearlzyme products produced different biological responses across the measured parameters. Pearlzyme 1 was associated with improvements in apparent ileal digestibility of several amino acids, whereas Pearlzyme 2 improved growth during grower phase and ileal cytokine expression following LPS challenge. These results suggest that the protease component mainly improved nutrient liberation and digestion, whereas the combined protease-probiotic product may have provided additional effects on FI and inflammatory responsiveness. These results align with previous broiler studies showing that exogenous proteases can improve energy utilization and amino acid digestibility (Amerah et al., 2017), and that probiotics can modulate gut function, barrier-related traits, and immune responses (Li et al., 2015). Dietary supplementation with PAR1 or PAR2 had limited effects on BW, BWG, FI, and FCR over the entire 21-d experimental period, indicating that the overall growth response to the additives was modest under the conditions of the current study. However, PAR2 improved BWG and FI during the grower phase (d 15–21), suggesting that the benefits of the protease-probiotic combination may become more apparent as birds age. This phase-specific response may reflect the increasing FI and digestive activity that occur as broilers mature, which can increase the opportunity for exogenous enzymes to act on dietary substrates and improve nutrient availability (Lee et al., 2023; Park et al., 2020). In addition, the probiotic components in PAR2 may have supported gut function or FI regulation during this period, contributing to the observed improvement in growth performance (Yu et al., 2022). Similar age-dependent responses to exogenous protease supplementation have been reported in broilers, where improvements in nutrient utilization and growth performance are often more evident during later growth phases when nutrient demand and digestive capacity are greater (Duque-Ramírez et al., 2023). Exogenous proteases hydrolyze peptide bonds in dietary proteins, increasing the availability of absorbable amino acids and improving ileal protein digestibility in broilers (Olukosi et al., 2015). These enzymes may also reduce the amount of undigested protein entering the hindgut, thereby limiting microbial fermentation and the production of harmful metabolites such as ammonia and biogenic amines (Diether and Willing, 2019; Gilbert et al., 2018). Protease responses are often more pronounced in diets with reduced protein levels or marginal nutrient supply, where enzymatic hydrolysis can compensate for incomplete digestion to improve the efficiency of feed nutrient utilization (Liu et al., 2023a; Ndazigaruye et al., 2019). Both PAR1 and PAR2 significantly improved AME, AMEn, gross energy digestibility, and dry matter digestibility during the grower phase compared with the control diet, with no differences observed between the two supplements. These improvements averaged approximately 3-4% for AME and AMEn, highlighting the role of exogenous proteases in improving energy utilization. Proteases enhance protein hydrolysis in the gastrointestinal tract, releasing amino acids and peptides and reducing the presence of undigested protein fractions that may otherwise interfere with nutrient digestion (Cowieson and Adeola, 2005; Olukosi et al., 2015). Improved protein degradation can also enhance the accessibility of other nutrients within the feed matrix, including starch, thereby supporting more efficient digestion and absorption of dietary energy (Cowieson et al., 2019). The equivalence of PAR1 and PAR2 for all energy measures, despite PAR1 alone improving amino acid digestibility, indicates that the energy response was driven by the protease and did not depend on the additional amino acid liberation observed with PAR1. Such dissociation, an energy benefit without a corresponding probiotic effect and an amino acid benefit without a corresponding energy effect, suggests that the two products acted on largely independent aspects of nutrient utilization rather than through a shared pathway. Nitrogen utilization data provided additional insight into the effects of the supplements on protein use. PAR2 increased nitrogen intake and total nitrogen retention compared with the control diet, whereas nitrogen retention efficiency was not significantly altered. Because PAR2 also increased FI during the same period, the greater nitrogen retention might indicate increased nitrogen consumption combined with maintained retention efficiency rather than a direct improvement in the efficiency of nitrogen utilization. However, PAR1 numerically increased nitrogen retention but did not differ significantly from either the control or PAR2 treatments. These results suggest that the higher nitrogen retention observed with PAR2 was at least partly driven by increased FI rather than a distinct improvement in retention efficiency. Nevertheless, supplementation with exogenous proteases has been consistently associated with improved protein digestion and nitrogen utilization in broilers, largely through enhanced hydrolysis of dietary protein and greater amino acid availability for absorption (Cowieson and Adeola, 2005; Olukosi et al., 2015). By improving protein breakdown in the small intestine, proteases may also reduce the flow of undigested nitrogenous compounds to the hindgut, thereby decreasing nitrogen losses and improving overall nutrient utilization (Angel et al., 2011). The amino acid digestibility results suggest that PAR1 had the most direct effect on prececal protein digestion. Birds fed PAR1 showed higher apparent ileal digestibility of threonine, phenylalanine, tyrosine, and cysteine compared with those fed the control diet, with several additional amino acids showing numerical improvements. Such amino acid-specific responses are consistent with previous reports indicating that exogenous proteases do not uniformly increase digestibility of all amino acids but instead exert greater effects on those that are more susceptible to incomplete hydrolysis or structural constraints within feed proteins (Cowieson et al., 2020; Hong et al., 2025). These improvements might indicate increased hydrolysis of dietary proteins and improved release of absorbable amino acids in the small intestine. The increases observed in threonine and cysteine digestibility may have particular physiological relevance, as threonine plays a major role in mucin synthesis and intestinal barrier maintenance, whereas cysteine contributes to sulfur amino acid metabolism and antioxidant-related pathways (Castro and Kim, 2020; Mao et al., 2011). However, PAR2 produced moderate improvements in individual amino acid digestibility, suggesting that the combined protease-probiotic product did not enhance prececal proteolysis beyond the protease-only formulation under the conditions of the present study. Not all studies report positive protease responses, and the effect is conditional rather than uniform. In broilers fed corn-soybean meal diets, several exogenous proteases increased in vitro crude protein digestibility yet reduced apparent ileal digestibility of crude protein and of all measured amino acids in vivo, which may be attributed to disruption of endogenous trypsin and chymotrypsin activity at higher doses (Zheng et al., 2023). Protease responses have also depended on the presence of other enzymes; in a broiler study, protease alone did not improve AMEn, whereas only the combination of xylanase, amylase, and protease raised AMEn relative to a negative control (Amerah et al., 2017). These discrepancies are consistent with the meta-analytic finding that the digestibility benefit of protease diminishes as the inherent digestibility of the diet rises and is lost when carbohydrases or phytase are already present (Lee et al., 2018). In the present study, only 4 of the amino acids assayed responded significantly to PAR1, and PAR2 produced no further improvement, which is more in line with this conditional effect than with uniformly broad protease effects. However, PAR2 was associated with improved growth during the later phase and reduced cytokine expression following LPS challenge. This difference between digestibility and physiological responses indicates that the probiotic components in PAR2 may have influenced host responses through mechanisms beyond direct nutrient hydrolysis. Consequently, while PAR1 appeared to improve nutrient digestibility more directly, PAR2 may have improved intestinal homeostasis and inflammatory resilience, which could contribute to improved FI and performance under immune challenge conditions. Similar differences between enzyme-driven improvements in nutrient digestibility and probiotic-mediated effects on gut health and immune responses have been reported in broiler nutrition studies (Dersjant-Li et al., 2016; Wealleans et al., 2017; Zaghari et al., 2020). In LPS-challenged birds, intestinal morphology was not affected by dietary treatment in the duodenum, jejunum, or ileum. Measurements of VH, CD, and VH:CD were similar among the treatments, indicating that the supplements did not substantially alter intestinal histomorphology at the sampling point evaluated in the current study. This lack of structural change may be related to the acute nature of the LPS challenge and the relatively short interval between LPS administration and tissue collection. Lipopolysaccharide induces a rapid systemic inflammatory response characterized primarily by changes in immune signaling and cytokine expression, which often occur earlier than measurable alterations in intestinal morphology (Anderson et al., 2026; Choppa et al., 2025). Structural remodeling of the intestinal epithelium typically requires a longer time frame because villus and crypt architectures are regulated by epithelial cell proliferation and turnover processes that occur over several days (Creamer et al., 1961). Consequently, the absence of detectable differences in villus morphology does not necessarily indicate a lack of biological effect by treatments, particularly when dietary treatments influence molecular or immune-related parameters. Similar observations have been reported in broiler studies where dietary additives altered inflammatory signaling or gut barrier function without producing immediate changes in villus structure following short-term immune challenges (Chen et al., 2018; Liu et al., 2023b; Zhang et al., 2022). Tight junction gene expression showed limited responses to dietary treatment, with CLDN1 tending to be lower in the supplemented groups while OCLN expression remained unchanged. Previous studies have shown that inflammatory stimuli, including LPS, can alter tight junction protein expression; however, the relationship between transcript abundance and barrier function is not always consistent (Guo et al., 2013). In some cases, barrier dysfunction has been associated with reduced expression of occludin or claudins, but evaluation of a single marker alone is insufficient to define barrier status without complementary evidence such as protein expression, intestinal permeability measurements, or histological assessment (Hossain et al., 2026; Suzuki, 2013). In the present study, the absence of changes in OCLN expression and intestinal morphology suggests that neither supplement substantially altered structural barrier integrity at 4 h following LPS challenge. This observation is consistent with reports indicating that early inflammatory responses are often reflected more strongly in cytokine signaling than in immediate changes in epithelial junctional structure (Guo et al., 2013). Therefore, the current data indicate that dietary treatments had minimal effects on the measured tight junction transcripts under the acute challenge conditions evaluated in the present study. The most pronounced intestinal response to LPS challenge in the current study was observed in cytokine gene expression. Birds fed PAR2 had lower ileal IL-1β and IL-10 expression compared with birds fed the control or PAR1 diets, whereas iNOS, COX-2, and IFN-γ expression were not significantly affected. The reduction in IL-1β suggests that PAR2 attenuated the local pro-inflammatory response induced by LPS. IL-1β is a key mediator of innate immune activation and is commonly upregulated during endotoxin exposure in poultry, reflecting activation of inflammatory signaling pathways in intestinal tissues (Dinarello, 2018). The simultaneous reduction in IL-10 expression may appear counterintuitive but also indicate a lower overall inflammatory stimulus. IL-10 is an anti-inflammatory cytokine that is frequently upregulated as a regulatory response to excessive immune activation; therefore, lower IL-10 expression alongside reduced IL-1β may indicate that the inflammatory cascade itself was less strongly activated in PAR2-fed birds (Iyer and Cheng, 2012; Kogut and Arsenault, 2017). However, the lack of difference in iNOS, COX-2, and IFN-γ expression suggests that the immunomodulatory effects of PAR2 were selective rather than broadly suppressive across all inflammatory pathways. Probiotic responses of cytokines are inconsistent in literature. A meta-analysis of 106 broiler trials found that probiotic effects on growth performance varied substantially across genera and production settings, with Lactobacillus-based products in particular often producing non-significant responses (Bilal et al., 2026), and a separate meta-analysis reported that probiotics improved villus height and modulated cytokine expression under challenge while not significantly affecting growth performance (Yosi and Metzler-Zebeli, 2023). The selective cytokine response observed in the current study is consistent with this pattern of partial rather than uniform probiotic effects. Such targeted modulation of cytokine signaling has been reported previously in broiler studies evaluating probiotic supplementation, where improvements in immune homeostasis occurred without uniform changes across all measured inflammatory mediators (Adhikari et al., 2019; Yu et al., 2022). Probiotic microorganisms, particularly Bacillus species, can influence host immune responses by modulating gut microbial communities, altering microbial metabolite production, and interacting with intestinal immune cells, thereby helping to maintain balanced immune responses during inflammatory challenges (Adhikari et al., 2019; Jha et al., 2020). Overall, the results suggest that Pearlzyme 1 and Pearlzyme 2 acted through partly overlapping but distinct modes of action. Both products improved energy utilization, supporting a primary contribution of the protease component to nutrient release and digestion. Pearlzyme 1 showed clearer effects on apparent ileal digestibility of selected amino acids, indicating a stronger direct impact on prececal protein hydrolysis. Pearlzyme 2, however, produced the most evident biological response in late BWG, FI, nitrogen retention, and attenuation of LPS-induced IL-1β and IL-10 expression, suggesting that the added probiotic component may have provided complementary benefits related to gut environment and immune regulation. Because the study did not include a probiotic-only treatment, the independent contribution of the probiotic fraction cannot be separated from that of the protease. Nevertheless, the contrasting response patterns between PAR1 and PAR2 support the hypothesis that combining protease activity with probiotic components may extend the benefits of supplementation beyond digestibility alone. Conclusion Dietary supplementation with Pearlzyme products improved nutrient and energy utilization in broilers during the grower phase, as evidenced by higher AME and AMEn values and improved gross energy and dry matter digestibility in both PAR1 and PAR2 fed birds com-pared with the control diet. PAR2 (protease + probiotic) also promoted higher FI and BWG during d 15-21, resulting in a tendency for higher final BW at d 21 and greater nitrogen. At the ileal level, PAR1 improved the apparent digestibility of threonine, phenylalanine, ty-rosine, and cysteine, whereas PAR2 showed intermediate responses. Under acute LPS challenge, intestinal morphology was not affected by dietary treatment, and tight junction gene expression changes were minimal; however, PAR2 birds had significantly lower ileal IL-1β and IL-10 expression relative to the LPS-challenged control, suggesting a moderated inflammatory response. These results indicate that Pearlzyme supplementation can im-prove dietary energy utilization, and that combining protease with probiotic components may provide additional benefits on late-phase growth and inflammatory signaling, although further research is needed to clarify mechanisms and longer-term effects under commercial-relevant immune stress conditions including enteric diseases or pathogen infections. Disclosures The authors declare no conflicts of interest. The funder provided the Pearlzyme products used in this study but had no role in the study design, data collection, data analysis, data interpretation, manuscript preparation, or the decision to publish the results. Funding This work was supported by Pearlzyme Inc. and Soltonbiochem Inc. Data availability The datasets generated and analyzed during the current study are available from the corresponding author on request. Author Contribution Deependra Paneru: conducted the feeding trial, completed experiment design, formulated test diets, made the test diets, collected samples, completed data generation, analyses, and visualization, and wrote a draft of the manuscript. Venkata Sesha Reddy Choppa: conducted the trial, made test diets, monitored bird health, measured growth performance, collected samples, performed data analysis and data visualization and reviewed and edited the manuscript. Jihwan Lee: conducted the feeding trial, made test diets, monitored bird health, measured growth performance, performed data curation, collected samples, and reviewed and edited the manuscript. Henseo Ko: conducted the feeding trial, made test diets, monitored bird health, measured growth performance, performed data analyses, collected samples, and reviewed and edited the manuscript. Milan Kumar Sharma: conducted the feeding trial, made test diets, monitored bird health, measured growth performance, performed data analyses, collected samples, and reviewed and edited the manuscript. Woo Kyun Kim: led the project as the principal investigator, conceptualized the study, identified the main idea, obtained funding for the study, oversaw the project progress, supervised graduate students, and reviewed and edited the manuscript.